OmniAb (OABI) Net Margin (2022 - 2026)

OmniAb's (OABI) quarterly Net Margin came in at 53.42% in Q1 2026, up 38471.0% year-on-year from N/an in Q1 2025, and up 68.44% on a QoQ basis from 169.28% in Q4 2025.

OmniAb (OABI) Net Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Net Margin data on file, last reported at 53.42% in Q1 2026.

  • On a quarterly basis, Net Margin rose 38471.0% year-over-year to 53.42% in Q1 2026; TTM through Mar 2026 was 187.59%, a 4152.0% increase from a year earlier, with the FY2025 full-year figure at 347.04%, down 11199.0% from the prior year.
  • Net Margin for Q1 2026 stood at 53.42%, up from 169.28% in the prior quarter.
  • Over the last five years, Net Margin for OABI reached as high as 19.3% in Q4 2022 and fell as low as 738.05% in Q3 2025.
  • Historically, Net Margin has averaged 228.81% across 5 years, with a median of 179.03% in 2024.
  • Across the five-year window, Net Margin plunged 46279 bps in 2024 and jumped 38471 bps in 2026, its largest moves.
  • Year by year, Net Margin stood at 19.3% in 2022, then tumbled by 1610 bps to 291.44% in 2023, then jumped by 58 bps to 120.96% in 2024, then slumped by 40 bps to 169.28% in 2025, then soared by 68 bps to 53.42% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 53.42% in Q1 2026, 169.28% in Q4 2025, and 738.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn -53.42%

Historic Data

Download Data
DateValue
Mar 31, 2026 -53.42%
Dec 31, 2025 -169.28%
Sep 30, 2025 -738.05%
Jun 30, 2025 -407.36%
Mar 31, 2025 -438.13%
Dec 31, 2024 -120.96%
Sep 30, 2024 -392.45%
Jun 30, 2024 -179.03%
Mar 31, 2024 -498.84%
Dec 31, 2023 -291.44%
Sep 30, 2023 -287.35%
Jun 30, 2023 -212.04%
Mar 31, 2023 -36.05%
Dec 31, 2022 19.30%
Sep 30, 2022 -28.55%
Jun 30, 2022 -18.06%
Mar 31, 2022 -38.13%